Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SIGMAR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FBXO18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRMT112 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COMTD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YIF1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP164 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LIME1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR15A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MLEC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED13L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C21orf91 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTRHD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SKIL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADAMTS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF791 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CNPY2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDE4A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSSCA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on